BARUZZI, AGOSTINO
 Distribuzione geografica
Continente #
NA - Nord America 7.331
EU - Europa 5.589
AS - Asia 4.340
AF - Africa 313
SA - Sud America 244
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 8
Totale 17.845
Nazione #
US - Stati Uniti d'America 7.271
GB - Regno Unito 1.517
CN - Cina 1.387
SG - Singapore 1.338
DE - Germania 1.035
IT - Italia 828
VN - Vietnam 640
SE - Svezia 639
HK - Hong Kong 400
UA - Ucraina 353
RU - Federazione Russa 296
IN - India 286
FR - Francia 229
IE - Irlanda 199
BR - Brasile 183
NL - Olanda 114
ZA - Sudafrica 110
EE - Estonia 97
CI - Costa d'Avorio 87
JP - Giappone 67
KR - Corea 62
TG - Togo 61
JO - Giordania 49
CH - Svizzera 48
FI - Finlandia 46
BG - Bulgaria 38
CA - Canada 38
SC - Seychelles 38
AT - Austria 35
AR - Argentina 34
BE - Belgio 31
UZ - Uzbekistan 25
ES - Italia 19
MX - Messico 19
GR - Grecia 17
EU - Europa 16
BD - Bangladesh 13
IR - Iran 13
PL - Polonia 13
ID - Indonesia 12
LB - Libano 9
LT - Lituania 9
TR - Turchia 9
RO - Romania 8
EC - Ecuador 7
AU - Australia 6
PY - Paraguay 6
NG - Nigeria 5
DZ - Algeria 4
IQ - Iraq 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BQ - ???statistics.table.value.countryCode.BQ??? 3
CL - Cile 3
KZ - Kazakistan 3
MY - Malesia 3
TH - Thailandia 3
TN - Tunisia 3
VE - Venezuela 3
CO - Colombia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
MC - Monaco 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
RE - Reunion 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
Totale 17.845
Città #
Southend 1.306
Ashburn 872
Singapore 841
Fairfield 750
Chandler 643
Hong Kong 397
Ann Arbor 393
Houston 391
Frankfurt am Main 374
Wilmington 372
Seattle 356
Woodbridge 347
Santa Clara 275
Princeton 257
Cambridge 245
Jacksonville 245
Beijing 194
Dublin 194
Dong Ket 193
Hefei 173
Boardman 149
Nanjing 129
Padova 120
Westminster 120
Ho Chi Minh City 113
Bologna 105
Abidjan 87
Los Angeles 87
Berlin 75
Jinan 75
Saint Petersburg 72
Milan 70
Tokyo 67
Turin 66
Buffalo 65
Hanoi 61
Lomé 61
Seoul 59
Shenyang 53
Florence 50
Amman 49
Dallas 47
Dearborn 45
Washington 45
Helsinki 43
Nanchang 43
Rome 43
Changsha 42
Medford 41
Hebei 39
New York 39
Sofia 38
Bengaluru 34
Mülheim 34
San Diego 33
Bern 31
Brussels 31
Mahé 30
Tianjin 30
Guangzhou 28
Norwalk 25
Shanghai 25
Redwood City 24
Hangzhou 23
Jiaxing 23
Bremen 22
Redondo Beach 22
Zhengzhou 22
London 21
Haikou 20
Redmond 20
Verona 19
Des Moines 18
Olalla 18
Phoenix 18
São Paulo 18
Toronto 18
Yubileyny 17
Falkenstein 15
Falls Church 14
Vienna 14
Chengdu 13
Fuzhou 13
Ningbo 13
San Francisco 13
Düsseldorf 12
Taizhou 12
Bühl 11
Kuban 11
Pune 11
Amsterdam 10
Costa Mesa 10
Haiphong 10
Johannesburg 10
Biên Hòa 9
Boston 9
Can Tho 9
Chicago 9
Council Bluffs 9
Lanzhou 9
Totale 11.886
Nome #
A new potential biomarker for dementia with Lewy bodies 528
Aura uditiva in pazienti con epilessia uditiva 264
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. 244
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 241
Clinical features and long term outcome of epilepsy in periventricular nodular heterotopia. Simple compared with plus forms. 240
Autonomic innervation in multiple system atrophy and pure autonomic failure. 229
Messenger RNA processing is altered in autosomal dominant leukodystrophy 219
Defective Mitochondrial Adenosine Triphosphate Production in Skeletal Muscle From Patients With Dominant Optic Atrophy Due to OPA1 Mutations 209
Brain diffusion-weighted imaging in Friedreich's ataxia. 204
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 202
Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. 197
Videopolygraphic and functional MRI study of musicogenic epilepsy. A case report and literature review. 196
Sporadic fatal insomnia in a fatal familial insomnia pedigree. 195
Anhidrosis in multiple system atrophy: a preganglionic sudomotor dysfunction? 194
The effect of a clinically practical exercise on levodopa bioavailability and motor response in patients with Parkinson disease. 191
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III 190
A new case of Sando syndrome and retinitis pigmentosa with novel combination of compound heterozygous POLG mutations. 190
Immunoproteasome in cancer and neuropathologies: a new therapeutic target? 188
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 185
The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. 183
Endozepines in recurrent stupor. 179
Erratum to: Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 178
Fattori prognostici in 170 pazienti con epilessia temporale mesiale 175
Mesial temporal lobe epilepsy (MTLE): prognostic factors 175
Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. 174
Attività nervosa simpatica ed ipersonnia in pazienti con Sindrome delle Apnee Ostruttive nel Sonno. 173
Agrypnia Excitata: a microneurographic study of muscle sympathetic nerve activity. 172
Idebenone treatment in Leber's hereditary optic neuropathy. 172
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 170
Small fiber neuropathy in female patients with fabry disease. 170
Habituation of sympathetic sudomotor and vasomotor skin responses: neural and non-neural components in healthy subjects. 167
Severe impairment of Complex I-driven adenosine triphosphate synthesis in leber hereditarfy optic neuropathy cybrids 166
Preganglionic sudomotor nerve fiber lesion in a patient with Multiple System Atrophy and generalized anhidrosis. 164
Lateralizing value of the auditory aura in partial seizures. 164
miRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR. 164
Epilepsy in primary cerebral tumors: the characteristics of epilepsy at the onset (results from the PERNO study--Project of Emilia Romagna Region on Neuro-Oncology). 164
Oncocytic glioblastoma: a glioblastoma showing oncocytic changes and increased mitochondrial DNA copy number 164
Levetiracetam clinical pharmacokinetics in elderly and very elderly patients with epilepsy 163
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy 162
Prognostic factors in patients with mesial temporal lobe epilepsy 162
Un anno di follow-up nei pazienti con epilessia parziale che hanno completato il passaggio da carbamazepina a excarbazepina. 161
Anidrosi generalizzata: differenti sedi lesionali evidenziate attraverso la biopsia cutanea e la microneurografia. 161
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. 160
BRAF V600E mutation in neocortical posterior temporal epileptogenic gangliogliomas 160
A wide range of 3243A>G/tRNALeu(UUR) (MELAS) mutation loads may segregate in offspring through the female germline bottleneck. 159
Daytime sympathetic hyperactivity in OSAS is related to excessive daytime sleepiness. 156
The 13042G>A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype. 155
Effect of deep brain stimulation of the posterior hypothalamic area on the cardiovascular system in chronic cluster headache patients. 153
Attività nervosa simpatico muscolare in un paziente affetto da sindrome di Eaton-Lambert ed ipertensione arteriosa. 151
Effetto della CPAP e della terapia chirurgica sull'attività simpatico muscolare e sulla pressione arteriosa in un paziente con OSAS ed ipertensione. 151
Ictal characteristics of psychogenic nonepileptic seizures: what we have learned from video/EEG recordings - a literature review. 150
Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? 150
Idebenone treatment in patients with OPA1-mutant dominant optic atrophy. 149
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. 149
Simple and validated HPLC-UV analysis of levetiracetam in deproteinized plasma of patients with epilepsy. 148
Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. 148
Attività nervosa simpatico muscolare e pressione arteriosa in pazienti Tilt positivi e Tilt negativi con sincope vasovagale. 147
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. 147
Tailored surgery for drug-resistant epilepsy due to temporal pole encephalocele and microdysgenesis. 146
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy 145
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 143
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies 142
Dominant Optic Atrophy (DOA) and Sensorineural Hearing Loss: Clinical, Biochemical, Spectroscopic and Molecular Genetic Study of a Large Italian Pedigree Linked to a New Locus on Chromosome 16 141
Progetto Neurooncologia Emilia Romagna - PERNO 140
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. 140
Muscle and skin sympathetic activities in Ross syndrome 138
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. 137
Anhidrosis in patients trated with Topiramate. 137
Lacosamide therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. 134
Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients. 133
Melanopsin retinal ganglion cell loss in Alzheimer's disease 133
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power 133
Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy. 132
Focal myoclonus and dystonia associated with celiac disease. 131
Esagerata inibizione dell'attività simpatica indotta da stimoli di arousal in pazienti fobici con sincope vasovagale. 131
CPAP treatment lowers sympathetic nerve activity and blood pressure in hypertensive obstructive sleep apnoea patients. 130
SPORADIC FATAL INSOMNIA IN A FATAL FAMILIAL INSOMNIA PEDIGREE 129
Creutzfeldt-Jakob disease associated with the R208H mutation in the prion protein gene 129
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. 129
Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine 128
Fattori prognostici in 170 pazienti con epilessia temporale mesiale (ETM) 128
Il trattamento con CPAP riduce l'attività simpatica e la pressione arteriosa in pazienti con Sindrome delle Apnee Ostruttive nel Sonno ed ipertensione. 124
Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. 124
Extreme variability in genotype/phenotype correlation in an Italian family carrying the mtDNA A3243G/tRNALeu(UUR) MELAS mutation. 124
POLG mutations causing ophthalmoplegia, sensorimotor polyneuropathy, ataxia, and deafness. 121
SPARTACUS: underdiagnosis of chronic daily headache in primary care. 121
Lower wake resting sympathetic and cardiovascular activities in narcolepsy with cataplexy. 120
Levetiracetam therapy in patients with brain tumour and epilepsy 120
Polisomnographic and pharmacokinetic findings in levodopa-induced augmentation of restless legs syndrome. 119
Prognostic factors in patients with Mesial Temporal Lobe Epilepsy (MTLE): A preliminary study. 119
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 114
Peripheral autonomic neuropathy: diagnostic contribution of skin biopsy 113
Corrigendum: Messenger RNA processing is altered in autosomal dominant leukodystrophy [Human Molecular Genetics, 24 (2015) (2746-2756)] DOI:10.1093/hmg/ddv034 113
Arousal induces exaggerated inhibition of sympathetic nerve activity in phobic patients with a history of vasovagal syncope. 112
Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. 111
Generalised anhidrosis: different lesion sites demonstrated by microneurography and skin biopsy. 111
Prognostic factors in patients with mesial temporal lobe epilepsy (MTLE). 111
Polyneuropathy in patients with mitochondrial disorders: clinical, electrophysiological and genetic evaluations. 111
Parallel changes in resting muscle sympathetic nerve activity and blood pressure in a hypertensive OSAS patient demonstrate treatment efficacy. 111
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. 109
Totale 15.939
Categoria #
all - tutte 46.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.048 0 0 0 0 0 79 42 129 136 98 97 467
2021/20222.439 179 81 161 175 198 133 72 130 76 275 539 420
2022/20232.555 260 370 149 313 165 199 79 150 458 59 228 125
2023/2024820 54 122 80 84 100 208 42 41 24 30 10 25
2024/20252.343 73 290 189 184 490 136 163 50 28 159 48 533
2025/20263.170 439 446 496 414 700 675 0 0 0 0 0 0
Totale 18.105